Article
Clinical Insights Into the COL4A3 p.Gly407Arg Variant in Alport Syndrome.
Kidney360 - 1 Aug 2026
Gomes Ana Marta, Reis Cláudia Falcão, Dias Joana, Martins Pedro Moreira, Medeiros Nuno, Ferreira Graça, Faria Vitória, Malheiro Jorge, Lemos Carolina, Lopes Daniela, Beirão Idalina
Abstract excerpt
KEY POINTS: Phenotypic variability remains significant among patients with the monoallelic COL4A3 p.Gly407Arg variant, despite shared environmental backgrounds. Proteinuria ≥500 mg/g is a strong predictor of renal function decline and adverse outcomes, highlighting its value as a key prognostic marker. Early nephrologic monitoring and timely initiation of renoprotective therapies, such as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
